Generation Bio
GBIO
GBIO
79 hedge funds and large institutions have $315M invested in Generation Bio in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 83 → 79 (-4)
15% less call options, than puts
Call options by funds: $29K | Put options by funds: $34K
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
79
Holding in Top 10
1
Calls
$29K
Puts
$34K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$718K | |
| 3 | +$548K | |
| 4 |
BlackRock
New York
|
+$498K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$497K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.53M | |
| 3 | -$825K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$564K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$280K |